Natural Product: NPC573112

Natural Product IDNPC573112
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
3-[[(2~{R},3~{S},4~{S},5~{S},6~{S})-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]methoxy]-3-oxo-propanoic acid
IUPAC Name 3-[[(2~{R},3~{S},4~{S},5~{S},6~{S})-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]methoxy]-3-oxo-propanoic acid
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey SSLQZEOVXSUHHA-MEOHWMTASA-N
Standard InCHI InChI=1S/C24H22O14/c25-10-3-1-9(2-4-10)12-5-11(26)18-13(36-12)6-14(19(30)21(18)32)37-24-23(34)22(33)20(31)15(38-24)8-35-17(29)7-16(27)28/h1-6,15,20,22-25,30-34H,7-8H2,(H,27,28)/t15-,20-,22+,23+,24-/m1/s1
SMILES O=C(O)CC(=O)OC[C@H]1O[C@@H](OC2=CC3=C(C(O)=C2O)C(=O)C=C(C2=CC=C(O)C=C2)O3)[C@@H](O)[C@@H](O)[C@@H]1O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   534.1 Volume:   486.133
?
Van der Waals volume.
Dense:   1.099 LogP:   0.304
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.051
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.102
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   8.0 Rigid Bonds:   26.0
TPSA:   233.65
?
Topological Polar Surface Area.
H-Bond Acceptor:   14.0
H-Bond Donor:   7.0 Rings:   4.0
Heavy Atoms:   14.0

MedChem Properties

QED Drug-Likeness Score:   0.118 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.136 Fsp3:   0.292
MCE-18:   93.032
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.451 Fluc inhibitor:   0.309
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.94
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.849
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.077 Promiscuous compounds:   0.625

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.451 MDCK Permeability:   -5.167
Pgp-inhibitor:   0.0 Pgp-substrate:   0.057
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.003
20% Bioavailability (F20%):   0.052 30% Bioavailability (F30%):   0.223
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.542
Plasma Protein Binding (PPB):   82.687% Volume Distribution (VD):   -0.084
Fu: 14.763%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.983
OATP1B3 inhibitor:   0.999 BCRP inhibitor:   0.053
BSEP inhibitor:   0.066

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.997
HLM stability:   0.003
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.821 Half-life (T1/2):  3.262

ADMET: Toxicity

hERG Blockers:  0.007 hERG Blockers (10um):  0.06
Human Hepatotoxicity (H-HT):  0.259 Drug-induced Liver Injury (DILI):  0.828
AMES Toxicity:  0.355 Rat Oral Acute Toxicity:  0.091
Maximum Recommended Daily Dose:  0.156 Skin Sensitization:  0.848
Carcinogencity:  0.135 Eye Corrosion:  0.0
Eye Irritation:  0.614 Respiratory Toxicity:  0.032
Drug-induced Neurotoxicity:  0.001 Ototoxicity:  0.83
Hematotoxicity:  0.134 Drug-induced Nephrotoxicity:  0.476
Genotoxicity:  0.923 RPMI-8226 Immunitoxicity:  0.045
A549 Cytotoxicity:  0.007 Hek293 Cytotoxicity:  0.071
BCF:   0.23
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.69
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.054
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.397
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2789 Bryum pseudotriquetrum Species Bryaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO2789 Bryum pseudotriquetrum Species Bryaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC573112 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8046 Intermediate Similarity NPC64051
0.7283 Intermediate Similarity NPC229409
0.7065 Intermediate Similarity NPC46202
0.6941 Remote Similarity NPC146792
0.6818 Remote Similarity NPC43211
0.6778 Remote Similarity NPC477848
0.6593 Remote Similarity NPC172807
0.6111 Remote Similarity NPC58716
0.6067 Remote Similarity NPC45618
0.6 Remote Similarity NPC270675
0.6 Remote Similarity NPC195685
0.5978 Remote Similarity NPC237435
0.5876 Remote Similarity NPC44931
0.5865 Remote Similarity NPC599948
0.5833 Remote Similarity NPC254540
0.5825 Remote Similarity NPC472994
0.5755 Remote Similarity NPC472993
0.5729 Remote Similarity NPC211594
0.5728 Remote Similarity NPC298171
0.5714 Remote Similarity NPC121703
0.5686 Remote Similarity NPC479766
0.5591 Remote Similarity NPC84265
0.5579 Remote Similarity NPC115760
0.5577 Remote Similarity NPC101636
0.5532 Remote Similarity NPC27942
0.5481 Remote Similarity NPC479765
0.5472 Remote Similarity NPC603856
0.5435 Remote Similarity NPC331652
0.5376 Remote Similarity NPC39360
0.5376 Remote Similarity NPC29763
0.5376 Remote Similarity NPC210003
0.5347 Remote Similarity NPC473512
0.5347 Remote Similarity NPC129827
0.5333 Remote Similarity NPC477629
0.5319 Remote Similarity NPC93337
0.5312 Remote Similarity NPC282169
0.5263 Remote Similarity NPC105025
0.5244 Remote Similarity NPC198826
0.5196 Remote Similarity NPC22062
0.5196 Remote Similarity NPC473634
0.5196 Remote Similarity NPC210073
0.5196 Remote Similarity NPC3583
0.5196 Remote Similarity NPC138811
0.5192 Remote Similarity NPC470443
0.5146 Remote Similarity NPC204693
0.5104 Remote Similarity NPC245014
0.5102 Remote Similarity NPC181616
0.5048 Remote Similarity NPC65711
0.5047 Remote Similarity NPC80068

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC573112 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5978 Remote Similarity NPD4338 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data